Aerius

Aerius Special Precautions

desloratadine

Manufacturer:

Merck Sharp & Dohme

Distributor:

Zuellig Pharma

Marketer:

A. Menarini
Full Prescribing Info
Special Precautions
Desloratadine should be administered with caution in patients with a medical or family history of seizures. In particular, young children may be more susceptible to developing new seizures under desloratadine treatment. Healthcare providers may consider discontinuing desloratadine in patients who experience a seizure while on treatment.
Effects on ability to drive and use machines: No effects on the ability to drive and use machines have been observed (see Pharmacology: Pharmacodynamics under Actions).
Tablet: Efficacy and safety of AERIUS Tablets in children under 12 years of age have not been established.
Syrup: Efficacy and safety of AERIUS Syrup in children under 1 years of age have not been established.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in